FBXO16 and breast cancer: Depletion of FBXO16 resulted in increased malignancy because of aberrant nuclear accumulation of β‐catenin, emphasizing that elevated levels of FBXO16 in higher grades of breast cancer could be therapeutically beneficial to abrogate the β‐catenin driven malignancy.